Raymond Dwek - Jul 7, 2022 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Stock symbol
UTHR
Transactions as of
Jul 7, 2022
Transactions value $
-$521,186
Form type
4
Date filed
7/11/2022, 04:30 PM
Previous filing
May 26, 2022
Next filing
Sep 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $0 +2.16K $0.00 2.16K Jul 8, 2022 Direct F1
transaction UTHR Common Stock Sale -$521K -2.16K -100% $241.29 0 Jul 11, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Restricted Stock Unit Options Exercise $0 -2.16K -100% $0.00* 0 Jul 8, 2022 Common Stock 2.16K $0.00 Direct F3, F4
transaction UTHR Restricted Stock Unit Award $0 +1.75K $0.00 1.75K Jul 7, 2022 Common Stock 1.75K $0.00 Direct F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares received upon vesting of restricted stock units on July 8, 2022. Restricted stock units converted on a one-for-one basis into shares of common stock.
F2 This sale of common stock was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
F3 Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F4 Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.
F5 Annual non-employee director award.